SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-20-002317
Filing Date
2020-08-25
Accepted
2020-08-25 12:32:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d07422prnb_08242020.htm SC 13D 323880
2 LETTER FROM BVF PARTNERS ex991to13d07422prnb_082420.htm EX-99.1 29800
3 JOINT FILING AGREEMENT ex992to13d07422prnb_082420.htm EX-99.2 10251
4 GRAPHIC image_001.jpg GRAPHIC 2511
5 GRAPHIC image_003.jpg GRAPHIC 4170
  Complete submission text file 0000921895-20-002317.txt   374978
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Subject) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90643 | Film No.: 201130680
SIC: 2834 Pharmaceutical Preparations